Akebia Therapeutics
AKBA
$1.34
Share price
0.75%
Change (1 day)
47.25%
Change (1 year)
Categories
Akebia Therapeutics (AKBA) - Net assets
Net assets on the balance sheet as of December 2023 : -$30.59 M
According to Akebia Therapeutics's latest financial reports the company has -$30.59 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Akebia Therapeutics - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-30.59 M | -684.78% |
| 2022-12-31 | $5.23 M | -92.93% |
| 2021-12-31 | $74 M | -70.11% |
| 2020-12-31 | $0.24 B | -37.27% |
| 2019-12-31 | $0.39 B | -37.92% |
| 2018-12-31 | $0.63 B | 418.81% |
| 2017-12-31 | $0.12 B | 79.94% |
| 2016-12-31 | $68.12 M | -48% |
| 2015-12-31 | $0.13 B | 25.87% |
| 2014-12-31 | $0.10 B | 238.41% |
| 2013-12-31 | $30.75 M | -1247.81% |
| 2012-12-31 | $-2.68 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | -224,969.21% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | -130,089.54% | 🇨🇭 Switzerland |
 Amgen AMGN | $6.23 B | -20,476.67% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.13 B | -528.29% | 🇺🇸 USA |